In-hospital prescription of QT-prolonging drugs in a cohort of more than 100,000 patients

International Journal of Cardiology

Volumn 147, Issue 1, 2011, Pages 165-166

  Baptista, Rui ^a   Silva, Sebastião ^a   Dias, Patrícia ^a   Monteiro, Pedro ^a   Feio, José ^a   Providência, Luís A ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Amitriptyline adverse effects; Anti arrhythmia agents adverse effects; Anti bacterial agents adverse effects; Antidepressive agents adverse effects; Antipsychotic agents adverse effects; Cohort studies; Drug interactions; Drug prescriptions statistics numerical data; Drug synergism; Heart conduction system drug effects; Polypharmacy; QT interval; Risk factors; Torsades de Pointes chemically induced

Indexed keywords

AMIODARONE; AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; CHLORPROMAZINE; CISAPRIDE; CLARITHROMYCIN; ERYTHROMYCIN; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; INDAPAMIDE; LEVOFLOXACIN; OCTREOTIDE; PRESCRIPTION DRUG; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SALMETEROL; SERTRALINE; SUMATRIPTAN; TAMOXIFEN; VENLAFAXINE;

CARDIOVASCULAR RISK; CLINICAL FEATURE; COHORT ANALYSIS; DRUG SAFETY; DRUG USE; HOSPITAL CARE; HUMAN; LETTER; PRESCRIPTION; PRIORITY JOURNAL; QT PROLONGATION; RESPIRATORY TRACT INFECTION; TREATMENT PLANNING;

EID: 79951722635     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.09.076     Document Type: Article

References (6)

1. Liu BA, Juurlink DN. Drugs and the QT interval - caveat doctor. N Engl J Med Set. 2004;351(11):1053-6. (Pubitemid 39167509)
2. Drew BJ, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol Mar. 2010;55(9):934-47.
3. Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med Mar. 2004;350(10):1013-22. (Pubitemid 38269278)
4. Allen LaPointe NM, Curtis LH, Chan KA, et al. Frequency of high-risk use of QT-prolonging medications. Pharmacoepidemiol Drug Saf Jun. 2006;15(6):361-8. (Pubitemid 44018691)
5. Curtis LH, Østbye T, Sendersky V, et al. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. Am J Med Fev. 2003;114(2):135-41. (Pubitemid 36183596)
6. Roe CM, Odell KW, Henderson RR. Concomitant use of antipsychotics and drugs that may prolong the QT interval. J Clin Psychopharmacol Abr. 2003;23(2):197-200. (Pubitemid 36368798)